as on September 13, 2025 at 1:29 am IST
Day's Low
Day's High
5.08%
Downside
1.02%
Upside
52 Week's Low
52 Week's High
68.25%
Downside
39.59%
Upside
Check Milestone Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$166.6M
EPS (TTM)
-0.89
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-1.27
Industry PE ratio
0P/B Ratio
0PEG Ratio
0EBITDA
-54.9M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
456589700.00%
Track how Milestone Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.
Milestone Pharmaceuticals Inc in the last 5 years
Lowest (0.00x)
September 15, 2025
Industry (0.00x)
September 15, 2025
Today (-1.27x)
September 15, 2025
Highest (0.00x)
September 15, 2025
Today’s Price to Earnings Ratio: -1.27x
Compare market cap, revenue, PE, and other key metrics of Milestone Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $166.6M | -75.92% | -1.27 | 0.00% | |
BUY | $61.1B | 256.98% | -505.15 | -12.96% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $101.1B | 47.85% | 28.07 | 31.86% | |
BUY | $59.4B | -3.43% | 14.11 | 31.37% |
The Milestone Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Milestone Pharmaceuticals Inc investment value today
Current value as on today
₹1,34,744
Returns
₹34,744
(+34.74%)
Returns from Milestone Pharmaceuticals Inc Stock
₹29,605 (+29.61%)
Dollar Returns*
₹5,139 (+5.14%)
Based on 10 analysts
80.00%
Buy
20.00%
Hold
0.00%
Sell
Based on 10 analysts, 80% of analysts recommend a 'BUY' rating for Milestone Pharmaceuticals Inc. Average target price of $3.5
Get share price movements and forecasts by analysts on Milestone Pharmaceuticals Inc.
What analysts predicted
43.71%UPSIDE
Target Price
$3.5
Current Price
$1.97
Analyzed by
10 Analysts
Target
$3.50
Milestone Pharmaceuticals Inc target price $3.5, a slight upside of 43.71% compared to current price of $1.97. According to 10 analysts rating.
Search interest for Milestone Pharmaceuticals Inc Stock has decreased by -42% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 7 days, MIST stock has moved up by 12.0%
Profit Spike
Netprofit is up for the last 2 quarters, -20.76M → -12.96M (in $), with an average increase of 60.1% per quarter
Revenue Rich
Revenue is up for the last 2 quarters, -868.00K → 108.0K (in $), with an average increase of 903.7% per quarter
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 202.1%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 46.7%
Organisation | Milestone Pharmaceuticals Inc |
Headquarters | 1111 Dr. Frederik-Philips Boulevard, Montreal, QC, Canada, H4M 2X6 |
Industry | Pharmaceuticals: Major |
CEO | Mr. Joseph G. Oliveto M.B.A. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Roshan Girglani | Vice President of Marketing |
Mr. Jeff Moore | Vice President of Sales |
Mr. Lorenz Muller | Chief Commercial Officer |
Mr. Joseph G. Oliveto M.B.A. | CEO, President & Director |
Mr. Amit Hasija | CFO & Executive VP of Corporate Development |
Dr. David B. Bharucha FACC, M.D., Ph.D. | Chief Medical Officer |
Dr. Guy Rousseau | SVP of Regulatory Affairs and Quality Management |
Dr. Philippe Douville M.B.A., Ph.D. | Founder, Strategic Advisor & Member of Scientific Advisory Board |
Mr. Jeffrey Nelson | Chief Operating Officer |
Dr. Philip T. Sager FACC, FAHA, FHRS, M.D. | Chief Medical Advisor & Member of the Scientific Advisory Board |
Milestone Pharmaceuticals Inc share price today is $1.97 as on at the close of the market. Milestone Pharmaceuticals Inc share today touched a day high of $1.99 and a low of $1.87.
Milestone Pharmaceuticals Inc share touched a 52 week high of $2.75 on and a 52 week low of $0.63 on . Milestone Pharmaceuticals Inc stock price today i.e. is closed at $1.97,which is 28.36% down from its 52 week high and 215.00% up from its 52 week low.
Milestone Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Milestone Pharmaceuticals Inc (MIST) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Milestone Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Milestone Pharmaceuticals Inc share’s latest price of $1.97 as on September 13, 2025 at 1:29 am IST, you will get 5.0761 shares of Milestone Pharmaceuticals Inc. Learn more about
fractional shares .
Milestone Pharmaceuticals Inc stock has given -75.92% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?